After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Medical Instruments & Supplies industry segment, falling under the Healthcare sector. The current market capitalization of DENTSPLY Sirona Inc is $7.11B. A total of 1.73 million shares were traded on the day, compared to an average of 3.18M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, XRAY has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 78 BUYs and 14 SELLs from insiders. Insiders purchased 234,830 shares during that period but sold 63,067.
In the most recent transaction, LUCIER GREGORY T bought 10,000 shares of XRAY for 31.44 per share on Nov 22. After the transaction, the Director now owns 43,121 company shares. In a previous transaction on Nov 20, Campion Simon D bought 10,000 shares at 29.70 per share. XRAY shares that President, CEO & Member of BOD owns now total 243,930.
Among the insiders who bought shares, Coleman Glenn acquired of 10,000 shares on Nov 20 at a per-share price of $29.70. This resulted in the Executive VP & CFO holding 73,566 shares of XRAY after the transaction. In another insider transaction, BRANDT ERIC sold 6,200 shares at $42.17 per share on May 02. Company shares held by the Director now total 44,902.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. XRAY’s most recent ex-dividend date was 12/28/2023 when it declared a $0.14 quarterly dividend that was paid in cash on 1/12/2024. Previously, the company paid the dividend on 10/13/2023 with an ex-dividend date of 9/28/2023. The XRAY stock dividend was $0.14 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for XRAY in the last 3 months, the mean price target is $36.75 with high estimates of $42.00 and low estimates of $30.00. In terms of 52-week highs and lows, XRAY has a high of $43.24 and a low of $26.27.
As of this writing, XRAY has an earnings estimate of $0.43 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of $0.46 per share and a lower estimate of $0.42. The company reported an EPS of $0.51 in the last quarter, which was 18.60% higher than expectations of $0.43.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. XRAY’s latest balance sheet shows that the firm has $339.00M in Cash & Short Term Investments as of fiscal 2021. There were $2.29B in debt and $1.26B in liabilities at the time. Its Book Value Per Share was $15.93, while its Total Shareholder’s Equity was $5.00B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XRAY is Buy with a score of 3.83.
